Electromed - רווח נקי למניה בארבעת הרבעונים האחרונים ELMD

Competent management at Electromed, Inc. (ELMD) ensures transparency of financial flows and an absence of debt, which is supported by a market valuation confirmation via the price chart, where the EPS TTM stands at 48.40. The company generates revenue from the sale of lung cleansing devices and ancillary consumables, reducing costs through automation. High barriers to entry are guaranteed by SmartVest patents and FDA certification.
Electromed Inc - פילוחים אנליטיים ומדדי מפתח (ELMD)

Stable payments from Medicare and insurance companies support the margins of Electromed, Inc., which is directly reflected in profit dynamics. This indicator measures the annual growth rate of net income per share over the last twelve months, revealing the actual acceleration of the business. By analyzing the relative change in EPS YoY (ttm), an investor can separate fundamental growth from market noise. The positive trend confirms the effectiveness of the company's pricing strategy.